| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 10/05/1994 | EP0574511B1 Method and device for heterogeneous phase synthesis of macromolecules such as peptides, polynucleotides or oligosaccharides |
| 10/04/1994 | US5352756 Solid support for synthesis of peptides |
| 10/04/1994 | US5352578 Method of separating oligonucleotides from a mixture |
| 09/30/1994 | CA2119089A1 Tumor necrosis factor muteins |
| 09/29/1994 | WO1994022014A1 Parvovirus receptors and methods of use |
| 09/29/1994 | WO1994021822A1 Dna sequencing by mass spectrometry via exonuclease degradation |
| 09/29/1994 | WO1994021818A1 Process for typing hla-b using specific primers and probes sets |
| 09/29/1994 | WO1994021811A1 Thermostable dna topoisomerase v |
| 09/29/1994 | WO1994021799A1 USE OF PORCINE GAL α(1,3) GALACTOSYL TRANSFERASE IN XENOGRAFT THERAPIES |
| 09/29/1994 | WO1994021797A1 Nucleic acid pharmaceuticals |
| 09/29/1994 | WO1994021792A2 Inhibition of selected tumor growth with recombinant viral vectors |
| 09/29/1994 | WO1994021781A2 Extracellular signal-regulated kinase, sequences, and methods of production and use |
| 09/29/1994 | WO1994021681A1 Growth differentiation factor-8 |
| 09/29/1994 | WO1994021680A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 09/29/1994 | WO1994021666A1 Antisense molecules directed against a gene for the catalytic subunit of phosphatidylinositol 3-kinase |
| 09/29/1994 | WO1994021664A1 Antisense molecules directed against a tenascin gene |
| 09/29/1994 | WO1994021660A1 Cloned human alpha1c adrenergic receptor |
| 09/29/1994 | WO1994021243A1 Novel metal binding agents, and methods and compositions for their use to treat metal toxicity |
| 09/29/1994 | WO1994021240A2 Superparamagnetic particles, process for producing the same and their use |
| 09/29/1994 | WO1994021126A1 Nucleic acid coding for a tumor rejection antigen precursor |
| 09/29/1994 | WO1994021115A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 09/29/1994 | WO1994017792A3 Compositions and methods for transdermal drug delivery |
| 09/29/1994 | WO1994011522A3 Vector for the expression of therapy-relevant genes |
| 09/29/1994 | CA2159085A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 09/29/1994 | CA2158642A1 Dna sequencing by mass spectrometry via exonuclease degradation |
| 09/29/1994 | CA2158564A1 Parvovirus receptors and methods of use |
| 09/29/1994 | CA2158546A1 Inhibition of selected tumor growth with recombinant viral vectors |
| 09/29/1994 | CA2158345A1 Cloned human alpha 1c adrenergic receptor |
| 09/28/1994 | EP0617132A2 Probes and method to detect human immunodeficiency virus type 1 |
| 09/28/1994 | EP0617125A2 A novel transport protein gene from the Huntington's disease region |
| 09/28/1994 | EP0617047A1 Dye-labelled phosphoramadites |
| 09/28/1994 | EP0616612A1 Nuclease stable and binding competent oligomers and methods for their use |
| 09/28/1994 | EP0533906A4 Detection of dna/rna by fluorescence polarization |
| 09/28/1994 | EP0412964B1 Inhibition of htlv-iii by exogenous oligonucleotides |
| 09/28/1994 | EP0222835B1 Oral vaccines |
| 09/27/1994 | US5350687 Antibodies which bind to novel lymphokine related peptides |
| 09/27/1994 | US5350686 Microwave acceleration of enzyme-catalyzed modification of macromolecules |
| 09/24/1994 | CA2118675A1 Transport protein gene from the huntington's disease region |
| 09/22/1994 | DE4309333A1 Superparamagnetic particles, process for their production and use thereof |
| 09/21/1994 | EP0447442B1 Method for polymerase activity determination |
| 09/20/1994 | US5348868 Incubating with methylamine and tert-butylamine |
| 09/20/1994 | US5348855 Assay for nucleic acid sequences in an unpurified sample |
| 09/19/1994 | CA2119175A1 Nucleic acid pharmaceuticals |
| 09/16/1994 | CA2118824A1 Expression of pertussis holotoxin in bordetella pertussis |
| 09/15/1994 | WO1994020639A1 Over expession of single-stranded molecules |
| 09/15/1994 | WO1994020623A1 Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 09/15/1994 | WO1994020620A2 Cloning of the zymocin gene and use of zymocin in beverages |
| 09/15/1994 | WO1994020615A1 Bone stimulating factor |
| 09/15/1994 | WO1994020614A1 Allergenic protein and peptides from house dust mite and uses therefor |
| 09/15/1994 | WO1994020610A1 Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals |
| 09/15/1994 | WO1994020523A1 Tumor targeting with l-enantiomeric oligonucleotide conjugates of immunoreagents and of chelated radionuclides |
| 09/15/1994 | WO1994020521A1 Process for synthesizing and selecting sequences of covalently bound components |
| 09/15/1994 | WO1994020517A1 Gene transfer for treating a connective tissue of a mammalian host |
| 09/15/1994 | WO1994020113A1 The human c/ebp gene and vectors for its expression |
| 09/15/1994 | WO1994020090A1 Decontaminating clinical samples |
| 09/15/1994 | WO1994020079A1 Human brain phosphodiesterase |
| 09/15/1994 | WO1994019945A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 09/15/1994 | WO1994017091A3 Foldback triplex-forming oligonucleotides |
| 09/15/1994 | WO1994004688A3 Cationic peptides and method for production |
| 09/15/1994 | DE4308410A1 Process for the synthesis and selection of sequences composed of covalently linked building blocks |
| 09/15/1994 | CA2654420A1 Cloning and recombinant production of vespid venom enzymes, such as phospholiphase and hyaluronidase, and immunological therapies based thereon |
| 09/15/1994 | CA2157902A1 Tumour targeting with l-enantiomeric oligonucleotide conjugates of immunoreagents and of chelated radionuclides |
| 09/15/1994 | CA2157901A1 Bone stimulating factor |
| 09/15/1994 | CA2157782A1 Gene transfer for treating a connective tissue of a mammalian host |
| 09/15/1994 | CA2157589A1 The human c/ebp gene and vectors for its expression |
| 09/14/1994 | EP0614979A1 Hog cholera virus vaccine and diagnostic |
| 09/14/1994 | EP0614975A1 Glycoprotein hormone receptor molecules |
| 09/14/1994 | EP0614907A1 Dinucleotide and oligonucleotide analogues |
| 09/14/1994 | EP0614906A1 Mononucleotide analogues and intermediates therefor |
| 09/14/1994 | EP0614489A1 NOVEL HUMAN cdc25 GENES, ENCODED PRODUCTS AND USES THEREFOR |
| 09/14/1994 | EP0432162B1 Apparatus and method for automated separation of extra-chromosomal dna from a cell suspension |
| 09/13/1994 | US5346994 Solvent extraction with phenol, guanidinium and thiocyanate |
| 09/13/1994 | US5346670 Phthalocyanine and tetrabenztriazaporphyrin reagents |
| 09/07/1994 | EP0613945A2 Tumor suppressor gene merlin and uses thereof |
| 09/07/1994 | EP0613501A1 Oligonucleotides and their use in an assay for encephalopathies. |
| 09/07/1994 | CN1091583A Method for the production of proteins in plant fluids |
| 09/07/1994 | CA2117014A1 Mononucleotide analogues and intermediates therefor |
| 09/07/1994 | CA2117009A1 Dinucleotide and olignucleotide analogues |
| 09/06/1994 | US5344757 Process for the detection of nucleic acids |
| 09/02/1994 | CA2116465A1 Antiviral polynucleotide conjugates |
| 09/01/1994 | WO1994019493A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |
| 09/01/1994 | WO1994019488A1 Borrelia burgdorferi spirochaete-specific nucleic acid probes |
| 09/01/1994 | WO1994019482A1 Heterologous antigens in live cell vaccine strains |
| 09/01/1994 | WO1994019364A2 Nucleic acid probes chemically 5'(oh)- and/or 3'(oh)-modified for inserting one or more non-radioactive labeling elements thereat, and method for preparing same |
| 09/01/1994 | WO1994019363A1 Process for preparing phosphorothioate oligonucleotides |
| 09/01/1994 | WO1994019327A1 Nucleosides, their preparation and their use as therapeutic agents and as building blocks of synthetic oligonucleotides |
| 09/01/1994 | WO1994019023A1 Cyclobutyl antisense oligonucleotides, methods of making and use thereof |
| 09/01/1994 | WO1994019012A2 Compositions and methods of application of reactive antiviral polymers |
| 09/01/1994 | WO1994016103A3 Detection of synthetic oligonucleotides extracted from body fluids or tissues |
| 09/01/1994 | WO1994012638A3 Interleukin-3 (il-3) multiple mutation polypeptides |
| 09/01/1994 | CA2157041A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |
| 09/01/1994 | CA2156394A1 Compositions and methods of application of reactive antiviral polymers |
| 09/01/1994 | CA2156191A1 Heterologous antigens in live cell vaccine strains |
| 09/01/1994 | CA2155757A1 Nucleic acid probes chemically 5'(oh)- and/or 3'(oh)-modified for inserting one or more non-radioactive labelling elements thereat, and method for preparing same |
| 08/31/1994 | EP0612336A1 Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates |
| 08/31/1994 | EP0476014B1 Very large scale immobilized polymer synthesis |
| 08/31/1994 | EP0259475B1 Recombinant human endothelial cell growth factor |
| 08/31/1994 | CN1091469A PTP 1D, a novel protein tyrosine phosphatase |
| 08/30/1994 | US5342931 Process for purifying DNA on hydrated silica |
| 08/30/1994 | US5342757 Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof |